 |
|
Cost-effectiveness of chronic hepatitis C screening and treatment
Hye Won Lee, Hankil Lee, Beom Kyung Kim, Young Chang, Jae Young Jang, Do Young Kim
Clin Mol Hepatol. 2022;28(2):164-173. Published online 2021 Dec 27 DOI: https://doi.org/10.3350/cmh.2021.0193
|
|
Citations to this article as recorded by
 Quality Assurance for Hepatitis C Virus Point-of-Care Diagnostics in Sub-Saharan Africa
Evans Duah, Evans Mantiri Mathebula, Tivani Mashamba-Thompson
Diagnostics.2023; 13(4): 684. CrossRef Response to antiviral therapy for chronic hepatitis C and risk of hepatocellular carcinoma occurrence in Japan: a systematic review and meta-analysis of observational studies
Yoko Yamagiwa, Keitaro Tanaka, Keitaro Matsuo, Keiko Wada, Yingsong Lin, Yumi Sugawara, Tetsuya Mizoue, Norie Sawada, Hidemi Takimoto, Hidemi Ito, Tetsuhisa Kitamura, Ritsu Sakata, Takashi Kimura, Shiori Tanaka, Manami Inoue, Sarah Krull Abe, Shuhei Nomur
Scientific Reports.2023;[Epub] CrossRef Real-life experience of ledipasvir and sofosbuvir for HCV infected Korean patients: a multicenter cohort study
Soon Kyu Lee, Sung Won Lee, Hae Lim Lee, Hee Yeon Kim, Chang Wook Kim, Do Seon Song, U Im Chang, Jin Mo Yang, Sun Hong Yoo, Jung Hyun Kwon, Soon Woo Nam, Seok-Hwan Kim, Myeong Jun Song, Jaejun Lee, Hyun Yang, Si Hyun Bae, Ji Won Han, Heechul Nam, Pil Soo
The Korean Journal of Internal Medicine.2022; 37(6): 1167. CrossRef
|